Translational Research Trials (as of August 12, 2020)

ENGOT-ov47-TR /NOGGO-AGO TR2 

Leading group: NOGGO

Clinical Trial Study: Prospective study of HE4 serum level in patients with first platinum sensitive relapsed ovarian cancer.

Planned number of patients: 500

Participating groups:

A-AGO, AGO, BGOG, GEICO, MaNGO, MITO, NCRI

Planned start in May 2018